KELLY MCCARVER: Open Payments
NPI 1760015580 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$909 in 54 payments from 17 companies in 2025. Trend: 2023 $422 · 2024 $780 · 2025 $909
Food & beverage: $909
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 16 | $136 |
| GlaxoSmithKline, LLC. | 6 | $118 |
| SHIELD THERAPEUTICS INC | 3 | $110 |
| Lilly USA, LLC | 6 | $107 |
| Novo Nordisk Inc | 5 | $92 |
| PFIZER INC. | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| Exact Sciences Corporation | 2 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $25 |
Products named: ACCRUFER, TRELEGY ELLIPTA, PREVNAR 20, OTEZLA, FARXIGA, MOUNJARO, Ozempic, EVENITY.
Industry payments across TX — which companies pay providers there.
